Dysphagia After Chemoradiotherapy for Head-and-Neck Squamous Cell Carcinoma: Dose-Effect Relationships for the Swallowing Structures

International Journal of Radiation Oncology Biology Physics

Volumn 75, Issue 2, 2009, Pages 385-392

  Dirix, Piet ^a   Abbeel, Sarah ^a   Vanstraelen, Bianca ^a   Hermans, Robert ^a   Nuyts, Sandra ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Chemoradiotherapy; Dysphagia; Head and neck cancer; IMRT

Indexed keywords

ANDERSONS; CHEMORADIOTHERAPY; CISPLATINUM; CLINICAL PARAMETERS; DOSE EFFECTS; DOSIMETRIC PARAMETER; DYSPHAGIA; HEAD AND NECK CANCER; HEAD-AND-NECK SQUAMOUS CELL CARCINOMA; IMRT; MEAN DOSE; MULTI VARIATE ANALYSIS; PERFORMANCE STATUS; PRE-TREATMENT; QUALITY-OF-LIFE; TUMOR LOCALIZATION; UNIVARIATE ANALYSIS;

CELL MEMBRANES; CHEMOTHERAPY; DECISION MAKING; DOSIMETERS; DOSIMETRY; MULTIVARIANT ANALYSIS; MUSCLE; PHYSICAL THERAPY; QUALITY CONTROL;

BIOLOGICAL ORGANS;

CISPLATIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMORADIOTHERAPY; CANCER RADIOTHERAPY; CANCER THERAPY; CONTROLLED STUDY; DOSE RESPONSE; DOSIMETRY; DYSPHAGIA; FEMALE; FOLLOW UP; HEAD AND NECK CARCINOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION DOSE FRACTIONATION; SQUAMOUS CELL CARCINOMA; SWALLOWING; TUMOR LOCALIZATION;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; DEGLUTITION; DEGLUTITION DISORDERS; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; LARYNX; MALE; MIDDLE AGED; PHARYNGEAL MUSCLES; QUALITY OF LIFE; RADIATION INJURIES;

EID: 69549110113     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.11.041     Document Type: Article

References (39)

1. Pignon J.P., Bourhis J., Domenge C., Designe L., and MACH-NC Collaborative Group. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: Three meta-analyses of updated individual data. Lancet 355 (2000) 949-955
2. Bourhis J., Overgaard J., Audry H., et al. Hyperfractionated or accelerated radiotherapy in head and neck cancer: A meta-analysis. Lancet 368 (2006) 843-584
3. Lazarus C.L., Logemann J.A., Pauloski B.R., et al. Swallowing disorders in head and neck cancer patients treated with radiotherapy and adjuvant chemotherapy. Laryngoscope 106 (1996) 1157-1166
4. Eisbruch A., Lyden T., Bradford C.R., et al. Objective assessment of swallowing dysfunction and aspiration after radiation concurrent with chemotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys 53 (2002) 23-28
5. Nguyen N.P., Moltz C.C., Frank C.C., et al. Dysphagia following chemoradiation for locally advanced head and neck cancer. Ann Oncol 15 (2004) 383-388
6. Lawson J.D., Otto K., Grist W., and Johnstone P.A.S. Frequency of esophageal stenosis after simultaneous modulated accelerated radiation therapy and chemotherapy for head and neck cancer. Am J Otolaryngol 29 (2008) 13-19
7. Nuyts S., Dirix P., Clement P.M.J., et al. Impact of adding concomitant chemotherapy to hyperfractionated accelerated radiotherapy for advanced head and neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 73 (2009) 1088-1095
8. Nguyen N.P., Frank C., Moltz C.C., et al. Impact of dysphagia on quality of life after treatment of head-and-neck cancer. Int J Radiat Oncol Biol Phys 61 (2005) 772-778
9. Nguyen N.P., Frank C., Moltz C.C., et al. Aspiration rate following chemoradiation for head and neck cancer. Radiother Oncol 80 (2006) 302-306
10. Nguyen N.P., Smith H.J., Dutta S., et al. Aspiration occurrence during chemoradiation for head and neck cancer. Anticancer Res 27 (2007) 1669-1672
11. Robbins K.T. Barriers to winning the battle with head-and-neck cancer. Int J Radiat Oncol Biol Phys 53 (2002) 4-5
12. Eisbruch A. Dysphagia and aspiration following chemo-irradiation of head and neck cancer: Major obstacles to intensification of therapy. Ann Oncol 15 (2004) 363-364
13. Eisbruch A., Kim H.M., Terrell J.E., et al. Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer. Int J Radiat Oncol Biol Phys 50 (2001) 695-704
14. Maes A., Weltens C., Flamen P., et al. Preservation of parotid function with uncomplicated conformal radiotherapy. Radiother Oncol 63 (2002) 203-211
15. Rosenthal D.I., Lewin J.S., and Eisbruch A. Prevention and treatment of dysphagia and aspiration after chemoradiation for head and neck cancer. J Clin Oncol 24 (2006) 2636-2643
16. Eisbruch A., Levendag P.C., Feng F.Y., et al. Can IMRT or brachytherapy reduce dysphagia associated with chemoradiotherapy of head and neck cancer? The Michigan and Rotterdam experiences. Int J Radiat Oncol Biol Phys 69 (2007) S40-S42
17. Eisbruch A., Schwartz M., Rasch C., et al. Dysphagia and aspiration after chemoradiotherapy for head and neck cancer: Which anatomic structures are affected and can they be spared by IMRT?. Int J Radiat Oncol Biol Phys 60 (2004) 1425-1439
18. Feng F.Y., Kim H.M., Lyden T.H., et al. Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: Early-dose effect relationships for the swallowing structures. Int J Radiat Oncol Biol Phys 68 (2007) 1289-1298
19. Levendag P.C., Teguh D.N., Voet P., et al. Dysphagia disorders in patients with cancer of the oropharynx are significantly affected by the radiation therapy dose to the superior and middle constrictor muscle: A dose-effect relationship. Radiother Oncol 85 (2007) 64-73
20. Jensen K., Lambertsen K., and Grau C. Late swallowing dysfunction and dysphagia after radiotherapy for pharynx cancer: Frequency, intensity and correlation with dose and volume parameters. Radiother Oncol 85 (2007) 74-82
21. Caglar H.B., Tishler R.B., Othus M., et al. Dose to larynx predicts for swallowing complications after intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 72 (2008) 1110-1118
22. Meirovitz A., Murdoch-Kinch C.A., Schipper M., et al. Grading xerostomia by physicians or by patients after intensity-modulated radiotherapy of head-and-neck cancer. Int J Radiat Oncol Biol Phys 66 (2006) 445-453
23. Dirix P., Nuyts S., and Van den Bogaert W. Radiation-induced xerostomia in patients with head and neck cancer: A literature review. Cancer 107 (2006) 2525-2534
24. American Joint Committee on Cancer. Cancer staging manual. 6th ed. (2002), Springer-Verlag, New York
25. Nuyts S., Dirix P., Hermans R., et al. Early experience with a hybrid accelerated radiotherapy schedule for locally advanced head and neck cancer. Head Neck 29 (2007) 720-730
26. Logemann J.A., Pauloski B.R., Rademaker A.W., et al. Swallowing disorders in the first year after radiation and chemoradiation. Head Neck 30 (2008) 148-158
27. Trotti A. Toxicity in head and neck cancer: A review of trends and issues. Int J Radiat Oncol Biol Phys 47 (2000) 1-12
28. Machtay M., Moughan J., Trotti A., et al. Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: An RTOG analysis. J Clin Oncol 26 (2008) 3582-3589
29. Langendijk J.A., Doornaert P., Verdonck-de Leeuw I.M., et al. Impact of late treatment-realted toxicity on quality of life among patients with head and neck cancer treated with radiotherapy. J Clin Oncol 26 (2008) 3770-3776
30. Caudell J.J., Schaner P.E., Meredith R.F., et al. Factors associated with long-term dysphagia after definitive radiotherapy for locally advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 73 (2008) 410-415
31. Dörr W., and Hendry J.H. Consequential late effects in normal tissues. Radiother Oncol 61 (2001) 223-231
32. Trotti A., Bellm L.A., Epstein J.B., et al. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: A systematic literature review. Radiother Oncol 66 (2003) 253-262
33. Gillespie M.B., Brodsky M.B., Day T.A., et al. Swallowing-related quality of life after head and neck cancer treatment. Laryngoscope 114 (2004) 1362-1367
34. Dawson L., Anzai Y., Marsh L., et al. Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 46 (2000) 1117-1126
35. Bussels B., Maes A., Hermans R., et al. Recurrences after conformal parotid-sparing radiotherapy for head and neck cancer. Radiother Oncol 72 (2004) 119-127
36. Cannon D.M., and Lee N.Y. Recurrence in region of spared parotid gland after definitive intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 70 (2008) 660-665
37. Mittal B.B., Pauloski B.R., Haraf D.J., et al. Swallowing dysfunction-preventive and rehabilitation strategies in patients with head and neck cancers treated with surgery, radiotherapy, and chemotherapy: A critical review. Int J Radiat Oncol Biol Phys 57 (2003) 1219-1230
38. Jensen K., Jensen A.B., and Grau C. The relationship between observer-based toxicity scoring and patient assessed symptom severity after treatment for head and neck cancer. A correlative cross sectional study of the DAHANCA toxicity scoring system and the EORTC quality of life questionnaires. Radiother Oncol 78 (2006) 298-305
39. Logemann J.A., Pauloski B.R., Rademaker A.W., et al. Xerostomia: 12-Month changes in saliva production and its relationship to perception and performance of swallow function, oral intake, and diet after chemoradiation. Head Neck 25 (2003) 432-437